Related Experiment Video
Updated: May 31, 2026
09:54
Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells
Published on: April 18, 2019
Immunological considerations for embryonic and induced pluripotent stem cell banking
Craig J Taylor1, Eleanor M Bolton, J Andrew Bradley
1Histocompatibility and Immunogenetics, Tissue Typing Laboratory, Cambridge University Teaching Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK. craig.taylor@addenbrookes
Summary
Creating stem cell banks with HLA-typed human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) can overcome immune rejection. A small bank could provide matched tissue for most populations, addressing therapeutic challenges.
Area of Science:
- Regenerative Medicine
- Immunology
- Biotechnology
Background:
- Pluripotent stem cells (hESCs and iPSCs) offer great potential for treating human diseases.
- Allogeneic transplantation of stem cell-derived tissues risks immunological rejection due to human leucocyte antigens (HLA).
- Personalized stem cell therapy using patient-derived iPSCs is logistically challenging and costly for large-scale application.
Purpose of the Study:
- To propose stem cell banking as a strategy to overcome immunological barriers in stem cell transplantation.
- To evaluate the feasibility of HLA-matched stem cell banks for widespread therapeutic use.
Main Methods:
- Review of stem cell technologies and immunological challenges in transplantation.
- Analysis of HLA haplotype data to simulate the effectiveness of stem cell banks.
- Consideration of practical, financial, political, and ethical implications for stem cell bank establishment.
Main Results:
- A stem cell bank with approximately 10 carefully selected, HLA-typed cell lines could provide matched tissue for a significant portion of a target population.
- This strategy aims to mitigate the risk of immune rejection in allogeneic stem cell therapies.
Conclusions:
- Stem cell banking with HLA-typed hESCs and iPSCs is a viable strategy to address the immunological barrier in regenerative medicine.
- The establishment of such banks requires careful consideration of population genetics, logistics, cost, and ethical factors to ensure global accessibility and compatibility across diverse ethnic groups.
Related Concept Videos
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.